Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy

Frontiers in Oncology

Oncology

YuTing Liao¹  XiMin Pan²  XiaoChun Meng²  KeXin Niu²  Shuai Ye²  Yu Han³ 

[1] GE Healthcare Pharmaceutical Diagnostics, Guangzhou, China;The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China;The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China;

关键词: radiomics;    computed tomography;    progression-free survival;    colorectal liver metastases;    chemotherapy;   

DOI  :  10.3389/fonc.2023.1283480

 received in 2023-08-26, accepted in 2023-09-05,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Ye, Han, Pan, Niu, Liao and Meng